Effects of Flaxseed on Perimenopausal Symptoms: Findings From a Single-Blind, Randomized, Placebo-Controlled Study

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Oct 4

PMID 39364521

Authors

Rashmi Shrivastava

Sandeep Bhattacharya

Narsingh Verma

Abbas A Mehdi

Amita Pandey

Jamal A Ansari

Affiliations

Soon will be listed here.

Abstract

Background Flaxseed contains many phytoestrogens that share structural similarities with endogenous estrogens. It has beneficial properties that improve hormonal effects that may influence chronic disorders. Objective This study aims to evaluate the impact of flaxseed supplementation on perimenopausal syndrome symptoms and serum polyphenol metabolites enterodiol (ED) and enterolactone (EL). Methods Recruitment of 145 perimenopausal women from Queen Mary's Hospital OPD in K.G.M.U. Lucknow, India, was done for this single-blind randomized placebo-controlled experiment, considering inclusion and exclusion criteria. We randomly divided subjects into two groups using a computer-generated random number table. The intervention group A received 10 grams of flaxseed powder, while the placebo group B received 10 grams of roasted wheat flour for a continuous three months. We measured their demographic characteristics, menopausal symptoms score using the modified Kupperman's index (KI), the menopause rating scale (MRS), and the menopause-specific quality of life (MENQOL) intervention questionnaire. Moreover, using high-performance liquid chromatography (HPLC), biochemical parameters (ED, EL) were assessed both at baseline and after three months. For the statistical analysis, Statistical Product and Service Solutions (SPSS, version 24; IBM SPSS Statistics for Windows, Armonk, NY) was employed. Result The study involved 123 individuals, with 22 subjects losing out during follow-up. From baseline to follow-up comparison, the intervention group demonstrated an average percentage decline in the final score of the KI, MRS, and MENQOL intervention questionnaire of -47.25%, -54.05%, and -50.39%, respectively, while the placebo group demonstrated an average percentage decline of -3.83%, -4.91%, and -7.92%, respectively. From baseline to follow-up, ED and EL levels increased by 2.81-fold and 8.55-fold in the intervention group and decreased by 0.25-fold and 0.27-fold in the placebo group. Conclusion Following three months of supplementation, the intervention group showed substantially lower menopausal symptoms (p < 0.001), and ED and EL levels were considerably higher (p < 0.001). Therefore, flaxseed might ameliorate the symptoms associated with perimenopause.

Citing Articles

Anti-Oxidant and Anti-Cancer Properties of Flaxseed.

Stepien A, Trojniak J, Tabarkiewicz J Int J Mol Sci. 2025; 26(3).

PMID: 39940995 PMC: 11818310. DOI: 10.3390/ijms26031226.

References

Rapkin A . Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment. Am J Obstet Gynecol. 2007; 196(2):97-106. DOI: 10.1016/j.ajog.2006.05.056. View

Hutchins A, Martini M, Olson B, Thomas W, Slavin J . Flaxseed influences urinary lignan excretion in a dose-dependent manner in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2000; 9(10):1113-8. View

Frigo M, de Barros E, Dos Santos P, Peres G, Weber J, Zanelatto C . Effects of a Cereal Bar with a Combination of Phytoestrogens on the Climacteric Symptoms: A Placebo-Controlled, Randomized Trial. J Am Nutr Assoc. 2021; 41(3):325-332. DOI: 10.1080/07315724.2021.1884143. View

Pruthi S, Qin R, Terstreip S, Liu H, Loprinzi C, Shah T . A phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7. Menopause. 2011; 19(1):48-53. PMC: 3246070. DOI: 10.1097/gme.0b013e318223b021. View

Lee J, Lee C, Yoon S, Choi H . Effect of porcine placental extract on menopausal symptoms in postmenopausal women: A prospective, randomized, double-blind, placebo-controlled trial. Taiwan J Obstet Gynecol. 2020; 59(5):675-681. DOI: 10.1016/j.tjog.2020.07.009. View

Polisseni A, de Araujo D, Polisseni F, Mourao Junior C, Polisseni J, Fernandes E . [Depression and anxiety in menopausal women: associated factors]. Rev Bras Ginecol Obstet. 2009; 31(1):28-34. DOI: 10.1590/s0100-72032009000100006. View

Egelioglu Cetisli N, Saruhan A, Kivcak B . The effects of flaxseed on menopausal symptoms and quality of life. Holist Nurs Pract. 2015; 29(3):151-7. DOI: 10.1097/HNP.0000000000000085. View

Gamache P, Acworth I . Analysis of phytoestrogens and polyphenols in plasma, tissue, and urine using HPLC with coulometric array detection. Proc Soc Exp Biol Med. 1998; 217(3):274-80. DOI: 10.3181/00379727-217-44232. View

Cruz E, Nina V, Figueredo E . Climacteric Symptoms and Sexual Dysfunction: Association between the Blatt-Kupperman Index and the Female Sexual Function Index. Rev Bras Ginecol Obstet. 2017; 39(2):66-71. PMC: 10309353. DOI: 10.1055/s-0037-1598603. View

10.

Colli M, Bracht A, Soares A, de Oliveira A, Boer C, de Souza C . Evaluation of the efficacy of flaxseed meal and flaxseed extract in reducing menopausal symptoms. J Med Food. 2012; 15(9):840-5. DOI: 10.1089/jmf.2011.0228. View

11.

Carmignani L, Pedro A, Costa-Paiva L, Pinto-Neto A . The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomized controlled trial. Maturitas. 2010; 67(3):262-9. DOI: 10.1016/j.maturitas.2010.07.007. View

12.

Toure A, Xueming X . Flaxseed Lignans: Source, Biosynthesis, Metabolism, Antioxidant Activity, Bio-Active Components, and Health Benefits. Compr Rev Food Sci Food Saf. 2021; 9(3):261-269. DOI: 10.1111/j.1541-4337.2009.00105.x. View

13.

Heinemann L, Potthoff P, Schneider H . International versions of the Menopause Rating Scale (MRS). Health Qual Life Outcomes. 2003; 1:28. PMC: 183844. DOI: 10.1186/1477-7525-1-28. View

14.

Wang X, Wang L, Di J, Zhang X, Zhao G . Prevalence and risk factors for menopausal symptoms in middle-aged Chinese women: a community-based cross-sectional study. Menopause. 2021; 28(11):1271-1278. PMC: 8547757. DOI: 10.1097/GME.0000000000001850. View

15.

Fukumitsu S, Aida K, Shimizu H, Toyoda K . Flaxseed lignan lowers blood cholesterol and decreases liver disease risk factors in moderately hypercholesterolemic men. Nutr Res. 2010; 30(7):441-6. DOI: 10.1016/j.nutres.2010.06.004. View

16.

Meeta M, Digumarti L, Agarwal N, Vaze N, Shah R, Malik S . Clinical Practice Guidelines on Menopause: *An Executive Summary and Recommendations: Indian Menopause Society 2019-2020. J Midlife Health. 2020; 11(2):55-95. PMC: 7688016. DOI: 10.4103/jmh.JMH_137_20. View

17.

Tao M, Shao H, Li C, Teng Y . Correlation between the modified Kupperman Index and the Menopause Rating Scale in Chinese women. Patient Prefer Adherence. 2013; 7:223-9. PMC: 3615846. DOI: 10.2147/PPA.S42852. View

18.

Lewis J, Hilditch J, Wong C . Further psychometric property development of the Menopause-Specific Quality of Life questionnaire and development of a modified version, MENQOL-Intervention questionnaire. Maturitas. 2005; 50(3):209-21. DOI: 10.1016/j.maturitas.2004.06.015. View

19.

Pallikadavath S, Ogollah R, Singh A, Dean T, Dewey A, Stones W . Natural menopause among women below 50 years in India: A population-based study. Indian J Med Res. 2017; 144(3):366-377. PMC: 5320842. DOI: 10.4103/0971-5916.198676. View

20.

Misra A, Chowbey P, Makkar B, Vikram N, Wasir J, Chadha D . Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India. 2009; 57:163-70. View